Dieter Kabelitz - Publications

Affiliations: 
Institute of Immunology and Serology University of Heidelberg, Germany, Heidelberg, Baden-Württemberg, Germany 

276 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Juraske C, Krissmer SM, Teuber ES, Parigiani MA, Strietz J, Wesch D, Kabelitz D, Minguet S, Schamel WW. Reprogramming of human γδ T cells by expression of an anti-CD19 TCR fusion construct (εTRuC) to enhance tumor killing. Journal of Leukocyte Biology. PMID 38149982 DOI: 10.1093/jleuko/qiad128  0.478
2023 Dong J, Holthaus D, Peters C, Koster S, Ehsani M, Quevedo-Olmos A, Berger H, Zarobkiewicz M, Mangler M, Gurumurthy RK, Hedemann N, Chumduri C, Kabelitz D, Meyer TF. γδ T cell-mediated cytotoxicity against patient-derived healthy and cancer cervical organoids. Frontiers in Immunology. 14: 1281646. PMID 38090581 DOI: 10.3389/fimmu.2023.1281646  0.384
2023 Hu Y, Hu Q, Li Y, Lu L, Xiang Z, Yin Z, Kabelitz D, Wu Y. γδ T cells: origin and fate, subsets, diseases and immunotherapy. Signal Transduction and Targeted Therapy. 8: 434. PMID 37989744 DOI: 10.1038/s41392-023-01653-8  0.454
2023 Al B, Bruno M, Röring RJ, Moorlag SJCFM, Suen TK, Klück V, Liu R, Debisarun PA, Gaal O, Bhat J, Kabelitz D, van de Veerdonk FL, Joosten LAB, Netea MG, Placek K. Peripheral T Cell Populations are Differentially Affected in Familial Mediterranean Fever, Chronic Granulomatous Disease, and Gout. Journal of Clinical Immunology. PMID 37714974 DOI: 10.1007/s10875-023-01576-7  0.455
2023 Kelm M, Darzentas F, Darzentas N, Kotrova M, Wessels W, Bendig S, Baldus CD, Lettau M, Gökbuget N, Kabelitz D, Brüggemann M, Chitadze G. Dominant T-cell Receptor Delta Rearrangements in B-cell Precursor Acute Lymphoblastic Leukemia: Leukemic Markers or Physiological γδ T Repertoire? Hemasphere. 7: e948. PMID 37670805 DOI: 10.1097/HS9.0000000000000948  0.398
2023 Saleh Z, Noroozi M, Eshkevar Vakili M, Kabelitz D, Nasrolahi H, Kalantar K. Targeting TRIM29 As a Negative Regulator of CAR-NK Cell Effector Function to Improve Antitumor Efficacy of These Cells: A Perspective. Current Molecular Medicine. PMID 37218209 DOI: 10.2174/1566524023666230510101525  0.384
2022 Tan AH, Cheung AMS, Kabelitz D. Editorial: Next generation γδ T cell-based tumor immunotherapy. Frontiers in Immunology. 13: 1041362. PMID 36248869 DOI: 10.3389/fimmu.2022.1041362  0.363
2022 Chitadze G, Kabelitz D. Immune surveillance in glioblastoma: Role of the NKG2D system and novel cell-based therapeutic approaches. Scandinavian Journal of Immunology. 96: e13201. PMID 35778892 DOI: 10.1111/sji.13201  0.303
2022 Bernicke B, Engelbogen N, Klein K, Franzenburg J, Borzikowsky C, Peters C, Janssen O, Junker R, Serrano R, Kabelitz D. Analysis of the Seasonal Fluctuation of γδ T Cells and Its Potential Relation with Vitamin D. Cells. 11. PMID 35563767 DOI: 10.3390/cells11091460  0.332
2022 Vakili ME, Faghih Z, Sarvari J, Doroudchi M, Hosseini SN, Kabelitz D, Kalantar K. Lower frequency of T stem cell memory (TSCM) cells in hepatitis B vaccine nonresponders. Immunologic Research. PMID 35445310 DOI: 10.1007/s12026-022-09278-9  0.309
2022 Kabelitz D. A Ménage à Trois of Cytotoxic Effector Cells: γδ T Cells Suppress NK Cells but Not CTLs. Cancer Immunology Research. OF1. PMID 35436335 DOI: 10.1158/2326-6066.CIR-22-0148  0.452
2022 Serrano R, Lettau M, Zarobkiewicz M, Wesch D, Peters C, Kabelitz D. Stimulatory and inhibitory activity of STING ligands on tumor-reactive human gamma/delta T cells. Oncoimmunology. 11: 2030021. PMID 35127253 DOI: 10.1080/2162402X.2022.2030021  0.461
2021 Serrano R, Coch C, Peters C, Hartmann G, Wesch D, Kabelitz D. Monocyte-dependent co-stimulation of cytokine induction in human γδ T cells by TLR8 RNA ligands. Scientific Reports. 11: 15231. PMID 34315922 DOI: 10.1038/s41598-021-94428-6  0.416
2021 Chitadze G, Lettau M, Peters C, Luecke S, Flüh C, Quabius ES, Synowitz M, Held-Feindt J, Kabelitz D. Erroneous expression of NKG2D on granulocytes detected by phycoerythrin-conjugated clone 149810 antibody. Cytometry. Part B, Clinical Cytometry. PMID 33749106 DOI: 10.1002/cyto.b.22001  0.404
2021 Kouakanou L, Peters C, Kabelitz D. Reply to: Vitamin C as a promoter of γδ T cells. Cellular & Molecular Immunology. PMID 33437051 DOI: 10.1038/s41423-020-00622-3  0.309
2020 Coffelt SB, Kabelitz D, Silva-Santos B, Kuball J, Born W, Bank I. Editorial: γδ T Cells in Cancer. Frontiers in Immunology. 11: 602411. PMID 33329597 DOI: 10.3389/fimmu.2020.602411  0.358
2020 Kabelitz D. Gamma Delta T Cells (γδ T Cells) in Health and Disease: In Memory of Professor Wendy Havran. Cells. 9. PMID 33266147 DOI: 10.3390/cells9122564  0.413
2020 Wesch D, Kabelitz D, Oberg HH. Tumor resistance mechanisms and their consequences on γδ T cell activation. Immunological Reviews. 298: 84-98. PMID 33048357 DOI: 10.1111/imr.12925  0.423
2020 Xu Y, Xiang Z, Alnaggar M, Kouakanou L, Li J, He J, Yang J, Hu Y, Chen Y, Lin L, Hao J, Li J, Chen J, Li M, Wu Q, ... ... Kabelitz D, et al. Allogeneic Vγ9Vδ2 T-cell immunotherapy exhibits promising clinical safety and prolongs the survival of patients with late-stage lung or liver cancer. Cellular & Molecular Immunology. PMID 32939032 DOI: 10.1038/S41423-020-0515-7  0.484
2020 Kabelitz D, Serrano R, Kouakanou L, Peters C, Kalyan S. Correction to: Cancer immunotherapy with γδ T cells: many paths ahead of us. Cellular & Molecular Immunology. PMID 32873864 DOI: 10.1038/S41423-020-00537-Z  0.425
2020 Serrano R, Wesch D, Kabelitz D. Correction: Serrano, R.; Wesch, D.; Kabelitz, D. Activation of Human γδ T Cells: Modulation by Toll-Like Receptor 8 Ligands and Role of Monocytes. 2020, , 713. Cells. 9. PMID 32867206 DOI: 10.3390/Cells9091977  0.376
2020 Bhat J, Bergmann AK, Waschina S, Nerl C, Kaleta C, Siebert R, Ammerpohl O, Kabelitz D. DNA methylation profile of a hepatosplenic gamma/delta T-cell lymphoma patient associated with response to interferon-α therapy. Cellular & Molecular Immunology. PMID 32820235 DOI: 10.1038/S41423-020-0518-4  0.37
2020 Kabelitz D, Serrano R, Kouakanou L, Peters C, Kalyan S. Cancer immunotherapy with γδ T cells: many paths ahead of us. Cellular & Molecular Immunology. PMID 32699351 DOI: 10.1038/S41423-020-0504-X  0.575
2020 Gonnermann D, Oberg HH, Lettau M, Peipp M, Bauerschlag D, Sebens S, Kabelitz D, Wesch D. Galectin-3 Released by Pancreatic Ductal Adenocarcinoma Suppresses γδ T Cell Proliferation but Not Their Cytotoxicity. Frontiers in Immunology. 11: 1328. PMID 32695112 DOI: 10.3389/Fimmu.2020.01328  0.549
2020 Jonescheit H, Oberg HH, Gonnermann D, Hermes M, Sulaj V, Peters C, Kabelitz D, Wesch D. Influence of Indoleamine-2,3-Dioxygenase and Its Metabolite Kynurenine on γδ T Cell Cytotoxicity against Ductal Pancreatic Adenocarcinoma Cells. Cells. 9. PMID 32384638 DOI: 10.3390/Cells9051140  0.529
2020 Kouakanou L, Peters C, Sun Q, Floess S, Bhat J, Huehn J, Kabelitz D. Vitamin C supports conversion of human γδ T cells into FOXP3-expressing regulatory cells by epigenetic regulation. Scientific Reports. 10: 6550. PMID 32300237 DOI: 10.1038/S41598-020-63572-W  0.484
2020 Serrano R, Wesch D, Kabelitz D. Activation of Human γδ T Cells: Modulation by Toll-Like Receptor 8 Ligands and Role of Monocytes. Cells. 9. PMID 32183240 DOI: 10.3390/Cells9030713  0.487
2020 Olusola BA, Kabelitz D, Olaleye DO, Odaibo GN. Early HIV infection is associated with reduced proportions of gamma delta T subsets as well as high creatinine and urea levels. Scandinavian Journal of Immunology. 91: e12868. PMID 32052490 DOI: 10.1111/Sji.12868  0.346
2020 Peters C, Kouakanou L, Kabelitz D. A comparative view on vitamin C effects on αβ- versus γδ T-cell activation and differentiation. Journal of Leukocyte Biology. PMID 32034803 DOI: 10.1002/Jlb.1Mr1219-245R  0.55
2020 Beucke N, Wesch D, Oberg HH, Peters C, Bochem J, Weide B, Garbe C, Pawelec G, Sebens S, Röcken C, Hashimoto H, Löffler MW, Nocerino P, Kordasti S, Kabelitz D, et al. Pitfalls in the characterization of circulating and tissue-resident human γδ T cells. Journal of Leukocyte Biology. PMID 31967358 DOI: 10.1002/Jlb.5Ma1219-296R  0.505
2020 Oberg HH, Peters C, Kabelitz D, Wesch D. Real-time cell analysis (RTCA) to measure killer cell activity against adherent tumor cells in vitro. Methods in Enzymology. 631: 429-441. PMID 31948561 DOI: 10.1016/Bs.Mie.2019.07.020  0.44
2020 Peters C, Kouakanou L, Oberg HH, Wesch D, Kabelitz D. In vitro expansion of Vγ9Vδ2 T cells for immunotherapy. Methods in Enzymology. 631: 223-237. PMID 31948549 DOI: 10.1016/Bs.Mie.2019.07.019  0.482
2019 Atashzar MR, Daryabor G, Kabelitz D, Kalantar K. Pyrin and Hematopoietic Interferon-Inducible Nuclear Protein Domain Proteins: Innate Immune Sensors for Cytosolic and Nuclear DNA. Critical Reviews in Immunology. 39: 275-288. PMID 32421969 DOI: 10.1615/Critrevimmunol.2020033114  0.335
2019 Oberg HH, Janitschke L, Sulaj V, Weimer J, Gonnermann D, Hedemann N, Arnold N, Kabelitz D, Peipp M, Bauerschlag D, Wesch D. Bispecific antibodies enhance tumor-infiltrating T cell cytotoxicity against autologous HER-2-expressing high-grade ovarian tumors. Journal of Leukocyte Biology. PMID 31833593 DOI: 10.1002/Jlb.5Ma1119-265R  0.477
2019 Tawfik D, Groth C, Gundlach JP, Peipp M, Kabelitz D, Becker T, Oberg HH, Trauzold A, Wesch D. TRAIL-Receptor 4 Modulates γδ T Cell-Cytotoxicity Toward Cancer Cells. Frontiers in Immunology. 10: 2044. PMID 31555275 DOI: 10.3389/Fimmu.2019.02044  0.525
2019 Oberg HH, Wesch D, Kalyan S, Kabelitz D. Regulatory Interactions Between Neutrophils, Tumor Cells and T Cells. Frontiers in Immunology. 10: 1690. PMID 31379875 DOI: 10.3389/Fimmu.2019.01690  0.559
2019 Lettau M, Dietz M, Vollmers S, Armbrust F, Peters C, Dang TM, Chitadze G, Kabelitz D, Janssen O. Degranulation of human cytotoxic lymphocytes is a major source of proteolytically active soluble CD26/DPP4. Cellular and Molecular Life Sciences : Cmls. PMID 31300870 DOI: 10.1007/S00018-019-03207-0  0.415
2019 Kouakanou L, Xu Y, Peters C, He J, Wu Y, Yin Z, Kabelitz D. Vitamin C promotes the proliferation and effector functions of human γδ T cells. Cellular & Molecular Immunology. PMID 31171862 DOI: 10.1038/S41423-019-0247-8  0.543
2019 Bhat J, Dubin S, Dananberg A, Quabius ES, Fritsch J, Dowds CM, Saxena A, Chitadze G, Lettau M, Kabelitz D. Histone Deacetylase Inhibitor Modulates NKG2D Receptor Expression and Memory Phenotype of Human Gamma/Delta T Cells Upon Interaction With Tumor Cells. Frontiers in Immunology. 10: 569. PMID 30972064 DOI: 10.3389/Fimmu.2019.00569  0.539
2019 Lettau M, Dietz M, Dohmen K, Leippe M, Kabelitz D, Janssen O. Granulysin species segregate to different lysosome-related effector vesicles (LREV) and get mobilized by either classical or non-classical degranulation. Molecular Immunology. 107: 44-53. PMID 30658247 DOI: 10.1016/J.Molimm.2018.12.031  0.53
2019 Peters C, Meyer A, Kouakanou L, Feder J, Schricker T, Lettau M, Janssen O, Wesch D, Kabelitz D. TGF-β enhances the cytotoxic activity of Vδ2 T cells. Oncoimmunology. 8: e1522471. PMID 30546961 DOI: 10.1080/2162402X.2018.1522471  0.491
2018 Melandri D, Zlatareva I, Chaleil RAG, Dart RJ, Chancellor A, Nussbaumer O, Polyakova O, Roberts NA, Wesch D, Kabelitz D, Irving PM, John S, Mansour S, Bates PA, Vantourout P, et al. The γδTCR combines innate immunity with adaptive immunity by utilizing spatially distinct regions for agonist selection and antigen responsiveness. Nature Immunology. PMID 30420626 DOI: 10.1038/S41590-018-0253-5  0.471
2018 Zeissig S, Rosati E, Dowds CM, Aden K, Bethge J, Schulte B, Pan WH, Mishra N, Zuhayra M, Marx M, Paulsen M, Strigli A, Conrad C, Schuldt D, Sinha A, ... ... Kabelitz D, et al. Vedolizumab is associated with changes in innate rather than adaptive immunity in patients with inflammatory bowel disease. Gut. PMID 29730603 DOI: 10.1136/Gutjnl-2018-316023  0.322
2018 Oberg HH, Kellner C, Gonnermann D, Sebens S, Bauerschlag D, Gramatzki M, Kabelitz D, Peipp M, Wesch D. Tribody [(HER2)xCD16] Is More Effective Than Trastuzumab in Enhancing γδ T Cell and Natural Killer Cell Cytotoxicity Against HER2-Expressing Cancer Cells. Frontiers in Immunology. 9: 814. PMID 29725336 DOI: 10.3389/Fimmu.2018.00814  0.507
2018 Bhat J, Kouakanou L, Peters C, Yin Z, Kabelitz D. Immunotherapy With Human Gamma Delta T Cells-Synergistic Potential of Epigenetic Drugs? Frontiers in Immunology. 9: 512. PMID 29593742 DOI: 10.3389/Fimmu.2018.00512  0.43
2018 Peters C, Kabelitz D, Wesch D. Regulatory functions of γδ T cells. Cellular and Molecular Life Sciences : Cmls. PMID 29520421 DOI: 10.1007/S00018-018-2788-X  0.531
2018 Lettau M, Armbrust F, Dohmen K, Drews L, Poch T, Dietz M, Kabelitz D, Janssen O. Mechanistic peculiarities of activation-induced mobilization of cytotoxic effector proteins in human T cells. International Immunology. PMID 29373679 DOI: 10.1093/Intimm/Dxy007  0.441
2018 Flüh C, Chitadze G, Adamski V, Hattermann K, Synowitz M, Kabelitz D, Held-Feindt J. NKG2D ligands in glioma stem-like cells: expression in situ and in vitro. Histochemistry and Cell Biology. 149: 219-233. PMID 29356965 DOI: 10.1007/S00418-018-1633-5  0.394
2018 Zeissig S, Rosati E, Dowds CM, Aden K, Bethge J, Schulte B, Pan WH, Falk-Paulsen M, Conrad C, Schuldt D, Sinha A, Nikolaus S, Arlt A, Kabelitz D, Ellrichmann M, et al. P371 Vedolizumab is associated with changes in innate rather than T-cell immunity in patients with inflammatory bowel disease Journal of Crohns & Colitis. 12. DOI: 10.1093/Ecco-Jcc/Jjx180.498  0.409
2017 Chitadze G, Flüh C, Quabius ES, Freitag-Wolf S, Peters C, Lettau M, Bhat J, Wesch D, Oberg HH, Luecke S, Janssen O, Synowitz M, Held-Feindt J, Kabelitz D. In-depth immunophenotyping of patients with glioblastoma multiforme: Impact of steroid treatment. Oncoimmunology. 6: e1358839. PMID 29147621 DOI: 10.1080/2162402X.2017.1358839  0.414
2017 Klausz K, Cieker M, Kellner C, Oberg HH, Kabelitz D, Valerius T, Burger R, Gramatzki M, Peipp M. A novel Fc-engineered human ICAM-1/CD54 antibody with potent anti-myeloma activity developed by cellular panning of phage display libraries. Oncotarget. 8: 77552-77566. PMID 29100408 DOI: 10.18632/Oncotarget.20641  0.432
2017 Nagel I, Bartels M, Duell J, Oberg HH, Ussat S, Bruckmueller H, Ottmann O, Pfeifer H, Trautmann H, Gökbuget N, Caliebe A, Kabelitz D, Kneba M, Horst HA, Hoelzer D, et al. Hematopoietic stem cell involvement in BCR-ABL1-positive ALL as potential mechanism of resistance to blinatumomab therapy. Blood. PMID 28827408 DOI: 10.1182/Blood-2017-05-782888  0.353
2017 Bhat J, Helmuth J, Chitadze G, Kouakanou L, Peters C, Vingron M, Ammerpohl O, Kabelitz D. Stochastics of cellular differentiation explained by epigenetics: The case of T-cell differentiation and functional plasticity. Scandinavian Journal of Immunology. PMID 28799233 DOI: 10.1111/Sji.12589  0.476
2017 Bhat J, Kabelitz D. Multilayer epigenetic analysis reveals novel transcription factor networks in CD8 T cells. Cellular & Molecular Immunology. PMID 28757613 DOI: 10.1038/Cmi.2017.46  0.404
2017 Chitadze G, Oberg HH, Wesch D, Kabelitz D. The Ambiguous Role of γδ T Lymphocytes in Antitumor Immunity. Trends in Immunology. 38: 668-678. PMID 28709825 DOI: 10.1016/J.It.2017.06.004  0.551
2017 Peipp M, Wesch D, Oberg HH, Lutz S, Muskulus A, van de Winkel JGJ, Parren PWHI, Burger R, Humpe A, Kabelitz D, Gramatzki M, Kellner C. CD20-Specific Immunoligands Engaging NKG2D Enhance γδ T Cell-Mediated Lysis of Lymphoma Cells. Scandinavian Journal of Immunology. PMID 28708284 DOI: 10.1111/Sji.12581  0.555
2017 Kabelitz D, Lettau M, Janssen O. Immunosurveillance by human γδ T lymphocytes: the emerging role of butyrophilins. F1000research. 6. PMID 28649364 DOI: 10.12688/F1000Research.11057.1  0.528
2017 Schneppenheim J, Loock AC, Hüttl S, Schweizer M, Lüllmann-Rauch R, Oberg HH, Arnold P, Lehmann CHK, Dudziak D, Kabelitz D, Lucius R, Lennon-Duménil AM, Saftig P, Schröder B. The Influence of MHC Class II on B Cell Defects Induced by Invariant Chain/CD74 N-Terminal Fragments. Journal of Immunology (Baltimore, Md. : 1950). PMID 28550201 DOI: 10.4049/Jimmunol.1601533  0.359
2017 Kerstein A, Schüler S, Cabral-Marques O, Fazio J, Häsler R, Müller A, Pitann S, Moosig F, Klapa S, Haas C, Kabelitz D, Riemekasten G, Wolters S, Lamprecht P. Environmental factor and inflammation-driven alteration of the total peripheral T-cell compartment in granulomatosis with polyangiitis. Journal of Autoimmunity. 78: 79-91. PMID 28040323 DOI: 10.1016/J.Jaut.2016.12.004  0.51
2017 Kerstein A, Müller A, Kabelitz D, Lamprecht P. Effector memory T‑cells in the pathogenesis of ANCA-associated vasculitides. Zeitschrift Fur Rheumatologie. 76: 14-17. PMID 26913717 DOI: 10.1007/S00393-016-0053-Y  0.366
2016 Peters C, Häsler R, Wesch D, Kabelitz D. Human Vδ2 T cells are a major source of interleukin-9. Proceedings of the National Academy of Sciences of the United States of America. 113: 12520-12525. PMID 27791087 DOI: 10.1073/Pnas.1607136113  0.492
2016 Nerdal PT, Peters C, Oberg HH, Zlatev H, Lettau M, Quabius ES, Sousa S, Gonnermann D, Auriola S, Olive D, Määttä J, Janssen O, Kabelitz D. Butyrophilin 3A/CD277-Dependent Activation of Human γδ T Cells: Accessory Cell Capacity of Distinct Leukocyte Populations. Journal of Immunology (Baltimore, Md. : 1950). PMID 27619996 DOI: 10.4049/Jimmunol.1600913  0.534
2016 Bhat J, Sosna J, Fritsch J, Quabius ES, Schütze S, Zeissig S, Ammerpohl O, Adam D, Kabelitz D. Expression of non-secreted IL-4 is associated with HDAC inhibitor-induced cell death, histone acetylation and c-Jun regulation in human gamma/delta T-cells. Oncotarget. PMID 27556516 DOI: 10.18632/Oncotarget.11462  0.357
2016 Kabelitz D. Human γδ T cells: From a neglected lymphocyte population to cellular immunotherapy: A personal reflection of 30years of γδ T cell research. Clinical Immunology (Orlando, Fla.). 172: 90-97. PMID 27444042 DOI: 10.1016/J.Clim.2016.07.012  0.552
2016 Oberg HH, Grage-Griebenow E, Adam-Klages S, Jerg E, Peipp M, Kellner C, Petrick D, Gonnermann D, Freitag-Wolf S, Röcken C, Sebens T, Vogel I, Becker T, Ebsen M, Kabelitz D, et al. Monitoring and functional characterization of the lymphocytic compartment in pancreatic ductal adenocarcinoma patients. Pancreatology : Official Journal of the International Association of Pancreatology (Iap) ... [Et Al.]. PMID 27424476 DOI: 10.1016/J.Pan.2016.07.008  0.393
2016 Chitadze G, Lettau M, Luecke S, Wang T, Janssen O, Fürst D, Mytilineos J, Wesch D, Oberg HH, Held-Feindt J, Kabelitz D. NKG2D- and T-cell receptor-dependent lysis of malignant glioma cell lines by human γδ T cells: Modulation by temozolomide and A disintegrin and metalloproteases 10 and 17 inhibitors. Oncoimmunology. 5: e1093276. PMID 27141377 DOI: 10.1080/2162402X.2015.1093276  0.546
2015 Kabelitz D, Déchanet-Merville J. Editorial: "Recent Advances in Gamma/Delta T Cell Biology: New Ligands, New Functions, and New Translational Perspectives". Frontiers in Immunology. 6: 371. PMID 26257738 DOI: 10.3389/Fimmu.2015.00371  0.521
2015 Hüttl S, Kläsener K, Schweizer M, Schneppenheim J, Oberg HH, Kabelitz D, Reth M, Saftig P, Schröder B. Processing of CD74 by the Intramembrane Protease SPPL2a Is Critical for B Cell Receptor Signaling in Transitional B Cells. Journal of Immunology (Baltimore, Md. : 1950). 195: 1548-63. PMID 26157172 DOI: 10.4049/Jimmunol.1403171  0.358
2015 Bhat J, Kabelitz D. γδ T cells and epigenetic drugs: A useful merger in cancer immunotherapy? Oncoimmunology. 4: e1006088. PMID 26155411 DOI: 10.1080/2162402X.2015.1006088  0.426
2015 Lettau M, Kabelitz D, Janssen O. Lysosome-Related Effector Vesicles in T Lymphocytes and NK Cells. Scandinavian Journal of Immunology. 82: 235-43. PMID 26118957 DOI: 10.1111/sji.12337  0.397
2015 Oberg HH, Kellner C, Gonnermann D, Peipp M, Peters C, Sebens S, Kabelitz D, Wesch D. γδ T cell activation by bispecific antibodies. Cellular Immunology. 296: 41-9. PMID 25979810 DOI: 10.1016/J.Cellimm.2015.04.009  0.536
2015 Gonnermann D, Oberg HH, Kellner C, Peipp M, Sebens S, Kabelitz D, Wesch D. Resistance of cyclooxygenase-2 expressing pancreatic ductal adenocarcinoma cells against γδ T cell cytotoxicity. Oncoimmunology. 4: e988460. PMID 25949900 DOI: 10.4161/2162402X.2014.988460  0.536
2015 Ebsen H, Lettau M, Kabelitz D, Janssen O. Subcellular localization and activation of ADAM proteases in the context of FasL shedding in T lymphocytes. Molecular Immunology. 65: 416-28. PMID 25745808 DOI: 10.1016/J.Molimm.2015.02.008  0.482
2015 Bhat J, Oberg HH, Kabelitz D. Modulation of human gamma/delta T-cell activation and phenotype by histone deacetylase inhibitors. Cellular Immunology. 296: 50-6. PMID 25708484 DOI: 10.1016/J.Cellimm.2015.01.019  0.523
2015 Aboul Naga SH, Dithmer M, Chitadze G, Kabelitz D, Lucius R, Roider J, Klettner A. Intracellular pathways following uptake of bevacizumab in RPE cells. Experimental Eye Research. 131: 29-41. PMID 25533679 DOI: 10.1016/J.Exer.2014.12.010  0.352
2015 Lettau M, Kabelitz D, Janssen O. SDF1α-induced interaction of the adapter proteins Nck and HS1 facilitates actin polymerization and migration in T cells. European Journal of Immunology. 45: 551-61. PMID 25359136 DOI: 10.1002/Eji.201444473  0.443
2015 Fazio J, Kalyan S, Wesch D, Kabelitz D. Inhibition of Human γδ T Cell Proliferation and Effector Functions by Neutrophil Serine Proteases Scandinavian Journal of Immunology. 80: 381-389. PMID 25345993 DOI: 10.1111/Sji.12221  0.539
2015 Chandrasekaran V, Kalyan S, Biel V, Lettau M, Nerdal PT, Oberg HH, Wesch D, Lindhorst TK, Kabelitz D. Novel synthesis of fluorochrome-coupled zoledronate with preserved functional activity on gamma/delta T cells and tumor cells Medchemcomm. 6: 919-925. DOI: 10.1039/C5Md00063G  0.533
2014 Oberg HH, Kellner C, Peipp M, Sebens S, Adam-Klages S, Gramatzki M, Kabelitz D, Wesch D. Monitoring Circulating γδ T Cells in Cancer Patients to Optimize γδ T Cell-Based Immunotherapy. Frontiers in Immunology. 5: 643. PMID 25566256 DOI: 10.3389/Fimmu.2014.00643  0.537
2014 Fritsch J, Stephan M, Tchikov V, Winoto-Morbach S, Gubkina S, Kabelitz D, Schütze S. Cell fate decisions regulated by K63 ubiquitination of tumor necrosis factor receptor 1. Molecular and Cellular Biology. 34: 3214-28. PMID 24980434 DOI: 10.1128/Mcb.00048-14  0.363
2014 Dopfer EP, Hartl FA, Oberg HH, Siegers GM, Yousefi OS, Kock S, Fiala GJ, Garcillán B, Sandstrom A, Alarcón B, Regueiro JR, Kabelitz D, Adams EJ, Minguet S, Wesch D, et al. The CD3 conformational change in the γδ T cell receptor is not triggered by antigens but can be enforced to enhance tumor killing. Cell Reports. 7: 1704-15. PMID 24857663 DOI: 10.1016/J.Celrep.2014.04.049  0.469
2014 Helm O, Mennrich R, Petrick D, Goebel L, Freitag-Wolf S, Röder C, Kalthoff H, Röcken C, Sipos B, Kabelitz D, Schäfer H, Oberg HH, Wesch D, Sebens S. Comparative characterization of stroma cells and ductal epithelium in chronic pancreatitis and pancreatic ductal adenocarcinoma Plos One. 9. PMID 24797069 DOI: 10.1371/Journal.Pone.0094357  0.435
2014 Lettau M, Kliche S, Kabelitz D, Janssen O. The adapter proteins ADAP and Nck cooperate in T cell adhesion. Molecular Immunology. 60: 72-9. PMID 24769494 DOI: 10.1016/J.Molimm.2014.03.017  0.49
2014 Voigt S, Philipp S, Davarnia P, Winoto-Morbach S, Röder C, Arenz C, Trauzold A, Kabelitz D, Schütze S, Kalthoff H, Adam D. TRAIL-induced programmed necrosis as a novel approach to eliminate tumor cells. Bmc Cancer. 14: 74. PMID 24507727 DOI: 10.1186/1471-2407-14-74  0.349
2014 Helm O, Held-Feindt J, Grage-Griebenow E, Reiling N, Ungefroren H, Vogel I, Krüger U, Becker T, Ebsen M, Röcken C, Kabelitz D, Schäfer H, Sebens S. Tumor-associated macrophages exhibit pro- and anti-inflammatory properties by which they impact on pancreatic tumorigenesis. International Journal of Cancer. Journal International Du Cancer. 135: 843-61. PMID 24458546 DOI: 10.1002/Ijc.28736  0.323
2014 Oberg HH, Peipp M, Kellner C, Sebens S, Krause S, Petrick D, Adam-Klages S, Röcken C, Becker T, Vogel I, Weisner D, Freitag-Wolf S, Gramatzki M, Kabelitz D, Wesch D. Novel bispecific antibodies increase γδ T-cell cytotoxicity against pancreatic cancer cells. Cancer Research. 74: 1349-60. PMID 24448235 DOI: 10.1158/0008-5472.Can-13-0675  0.479
2014 Kalyan S, Kabelitz D. When neutrophils meet T cells: Beginnings of a tumultuous relationship with underappreciated potential European Journal of Immunology. 44: 627-633. PMID 24435886 DOI: 10.1002/Eji.201344195  0.541
2014 Kalyan S, Chandrasekaran V, Quabius ES, Lindhorst TK, Kabelitz D. Neutrophil uptake of nitrogen-bisphosphonates leads to the suppression of human peripheral blood γδ T cells. Cellular and Molecular Life Sciences : Cmls. 71: 2335-46. PMID 24162933 DOI: 10.1007/S00018-013-1495-X  0.452
2014 Kabelitz D. Critical role of butyrophilin 3A1 in presenting prenyl pyrophosphate antigens to human γδ T cells. Cellular & Molecular Immunology. 11: 117-9. PMID 24097034 DOI: 10.1038/Cmi.2013.50  0.432
2014 Peters C, Oberg HH, Kabelitz D, Wesch D. Phenotype and regulation of immunosuppressive Vδ2-expressing γδ T cells. Cellular and Molecular Life Sciences : Cmls. 71: 1943-60. PMID 24091816 DOI: 10.1007/S00018-013-1467-1  0.552
2014 Schulz-Juergensen S, Marischen L, Wesch D, Oberg HH, Fändrich F, Kabelitz D, Burdelski M. Markers of operational immune tolerance after pediatric liver transplantation in patients under immunosuppression. Pediatric Transplantation. 17: 348-54. PMID 23692599 DOI: 10.1111/petr.12079  0.374
2014 Gierloff M, Nitsche T, Adam-Klages S, Liebs K, Hedderich J, Gassling V, Wiltfang J, Kabelitz D, Ail Y. In vitro comparison of different carrier materials with rat bone marrow MSCs Clinical Oral Investigations. 18: 247-259. PMID 23463148 DOI: 10.1007/S00784-013-0956-9  0.335
2014 Oberg H, Adam-Klages S, Peipp M, Kellner C, Sebens S, Gramatzki M, Kabelitz D, Wesch D. Immune monitoring of absolute cell numbers and functional capacity of circulating gammadelta T cells and other immune cells from cancer patients F1000research. 5. DOI: 10.7490/F1000Research.1095653.1  0.472
2014 Wesch D, Peipp M, Kellner C, Sebens S, Petrick D, Gramatzki M, Kabelitz D, Oberg H. Efficient strategy to overcome immunosuppression of the stromal composition on gammadelta T cells activity in pancreatic disease F1000research. 5. DOI: 10.7490/F1000Research.1095600.1  0.426
2014 Kalyan S, He W, Kabelitz D. The use of nitrogen-bisphosphonates to capture the potent anti-tumor arsenal of human peripheral blood γδ T cells for the treatment of bone cancer metastasis Bone Cancer: Primary Bone Cancers and Bone Metastases: Second Edition. 629-636. DOI: 10.1016/B978-0-12-416721-6.00052-2  0.378
2013 Ebsen H, Schröder A, Kabelitz D, Janssen O. Differential surface expression of ADAM10 and ADAM17 on human T lymphocytes and tumor cells. Plos One. 8: e76853. PMID 24130797 DOI: 10.1371/Journal.Pone.0076853  0.479
2013 Fazio J, Quabius ES, Müller A, Adam-Klages S, Wesch D, Sebens S, Kalyan S, Lamprecht P, Kabelitz D. Vδ2 T cell deficiency in granulomatosis with polyangiitis (Wegener's granulomatosis) Clinical Immunology. 149: 65-72. PMID 23891739 DOI: 10.1016/J.Clim.2013.06.003  0.536
2013 Kabelitz D, Kalyan S, Oberg HH, Wesch D. Human Vδ2 versus non-Vδ2 γδ T cells in antitumor immunity. Oncoimmunology. 2: e23304. PMID 23802074 DOI: 10.4161/Onci.23304  0.549
2013 Koop A, Sellami N, Adam-Klages S, Lettau M, Kabelitz D, Janssen O, Heidebrecht HJ. Down-regulation of the cancer/testis antigen 45 (CT45) is associated with altered tumor cell morphology, adhesion and migration. Cell Communication and Signaling : Ccs. 11: 41. PMID 23758873 DOI: 10.1186/1478-811X-11-41  0.33
2013 Chitadze G, Bhat J, Lettau M, Janssen O, Kabelitz D. Generation of Soluble NKG2D Ligands: Proteolytic Cleavage, Exosome Secretion and Functional Implications Scandinavian Journal of Immunology. 78: 120-129. PMID 23679194 DOI: 10.1111/Sji.12072  0.405
2013 Chitadze G, Lettau M, Bhat J, Wesch D, Steinle A, Fürst D, Mytilineos J, Kalthoff H, Janssen O, Oberg HH, Kabelitz D. Shedding of endogenous MHC class I-related chain molecules A and B from different human tumor entities: heterogeneous involvement of the "a disintegrin and metalloproteases" 10 and 17. International Journal of Cancer. 133: 1557-66. PMID 23526433 DOI: 10.1002/Ijc.28174  0.414
2013 Kabelitz D, Peters C, Wesch D, Oberg HH. Regulatory functions of γδ T cells. International Immunopharmacology. 16: 382-7. PMID 23481270 DOI: 10.1016/j.intimp.2013.01.022  0.473
2013 Kalyan S, Kabelitz D. Defining the nature of human γδ T cells: A biographical sketch of the highly empathetic Cellular and Molecular Immunology. 10: 21-29. PMID 23085947 DOI: 10.1038/Cmi.2012.44  0.497
2013 Kalyan S, Quabius ES, Wiltfang J, Mönig H, Kabelitz D. Can peripheral blood γδ T cells predict osteonecrosis of the jaw? An immunological perspective on the adverse drug effects of aminobisphosphonate therapy. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 28: 728-35. PMID 22991330 DOI: 10.1002/Jbmr.1769  0.465
2013 Kabelitz D, Kalyan S, Oberg HH, Wesch D. Human vδ2 versus non-vδ2 γδ t cells in antitumor immunity Oncoimmunology. 2. DOI: 10.4161/onci.23304  0.395
2012 Kabelitz D. CD277 takes the lead in human γδ T-cell activation. Blood. 120: 2159-2161. PMID 22977080 DOI: 10.1182/Blood-2012-07-442731  0.509
2012 Meyer T, Oberg H, Peters C, Martens I, Adam-Klages S, Kabelitz D, Wesch D. poly(I:C) costimulation induces a stronger antiviral chemokine and granzyme B release in human CD4 T cells than CD28 costimulation Journal of Leukocyte Biology. 92: 765-774. PMID 22750548 DOI: 10.1189/Jlb.0811407  0.374
2012 Kabelitz D, He W. The Multifunctionality of Human Vγ9Vδ2 γδ T Cells: Clonal Plasticity or Distinct Subsets? Scandinavian Journal of Immunology. 76: 213-222. PMID 22670577 DOI: 10.1111/J.1365-3083.2012.02727.X  0.563
2012 Lamprecht P, Kabelitz D. [T-cells in ANCA-associated vasculitis]. Zeitschrift Fur Rheumatologie. 70: 698-700. PMID 21979321 DOI: 10.1007/s00393-011-0780-z  0.376
2011 Kalyan S, Wesch D, Kabelitz D. Aminobisphosphonates and Toll-like receptor ligands: Recruiting Vγ9V82 T cells for the treatment of hematologic malignancy Current Medicinal Chemistry. 18: 5206-5216. PMID 22087821 DOI: 10.2174/092986711798184280  0.541
2011 Wesch D, Peters C, Oberg H, Pietschmann K, Kabelitz D. Modulation of γδ T cell responses by TLR ligands Cellular and Molecular Life Sciences. 68: 2357-2370. PMID 21560072 DOI: 10.1007/S00018-011-0699-1  0.524
2011 Kabelitz D. γδ T-cells: cross-talk between innate and adaptive immunity Cellular and Molecular Life Sciences. 68: 2331-2333. PMID 21541699 DOI: 10.1007/S00018-011-0696-4  0.443
2011 Marischen L, Wesch D, Oberg HH, Rosenstiel P, Trad A, Shomali M, Grötzinger J, Janssen O, Tchikov V, Schütze S, Kabelitz D. Functional expression of NOD2 in freshly isolated human peripheral blood γδ T cells. Scandinavian Journal of Immunology. 74: 126-34. PMID 21410503 DOI: 10.1111/j.1365-3083.2011.02560.x  0.454
2011 Oberg H, Juricke M, Kabelitz D, Wesch D. Regulation of T cell activation by TLR ligands. European Journal of Cell Biology. 90: 582-592. PMID 21292344 DOI: 10.1016/J.Ejcb.2010.11.012  0.491
2011 Koop A, Lepenies I, Braum O, Davarnia P, Scherer G, Fickenscher H, Kabelitz D, Adam-Klages S. Novel splice variants of human IKKε negatively regulate IKKε-induced IRF3 and NF-kB activation. European Journal of Immunology. 41: 224-234. PMID 21182093 DOI: 10.1002/Eji.201040814  0.311
2011 Friedrichs B, Siegel S, Reimer R, Barsoum A, Coggin J, Kabelitz D, Heidorn K, Schulte C, Schmitz N, Zeis M. High expression of the immature laminin receptor protein correlates with mutated IGVH status and predicts a favorable prognosis in chronic lymphocytic leukemia. Leukemia Research. 35: 721-9. PMID 21055809 DOI: 10.1016/J.Leukres.2010.10.002  0.32
2011 Paulsen M, Valentin S, Mathew B, Adam-Klages S, Bertsch U, Lavrik I, Krammer PH, Kabelitz D, Janssen O. Modulation of CD4+ T-cell activation by CD95 co-stimulation. Cell Death and Differentiation. 18: 619-31. PMID 21052094 DOI: 10.1038/cdd.2010.134  0.341
2010 Ussat S, Scherer G, Fazio J, Beetz S, Kabelitz D, Adam-Klages S. Human NK Cells Require Caspases for Activation- Induced Proliferation and Cytokine Release but not for Cytotoxicity Scandinavian Journal of Immunology. 72: 388-395. PMID 21039733 DOI: 10.1111/J.1365-3083.2010.02449.X  0.438
2010 Kabelitz D. Human gamma delta T lymphocytes for immunotherapeutic strategies against cancer F1000 Medicine Reports. 2: 2451-2452. PMID 20948839 DOI: 10.3410/M2-45  0.539
2010 Siegel S, Wirth S, Kabelitz D, Schmitz N, Zeis M. Identification of HLA-A*0201-presented T-cell epitopes derived from the tumor-associated antigen M-phase phosphoprotein II in patients with acute myeloid leukemia. Leukemia. 24: 1660-2. PMID 20613785 DOI: 10.1038/Leu.2010.147  0.391
2010 Kabelitz D, Fazio J, Adam-Klages S, Marget M, Oberg HH, Wesch D, Lamprecht P. gammadelta T-cells: basic features and potential role in vasculitis. Clinical and Experimental Rheumatology. 28: 104-9. PMID 20412714  0.446
2010 Oberg H, Ly TTH, Ussat S, Meyer T, Kabelitz D, Wesch D. Differential but Direct Abolishment of Human Regulatory T Cell Suppressive Capacity by Various TLR2 Ligands Journal of Immunology. 184: 4733-4740. PMID 20363971 DOI: 10.4049/Jimmunol.0804279  0.435
2010 Lettau M, Pieper J, Gerneth A, Lengl-Janßen B, Voss M, Linkermann A, Schmidt H, Gelhaus C, Leippe M, Kabelitz D, Janssen O. The adapter protein Nck: role of individual SH3 and SH2 binding modules for protein interactions in T lymphocytes. Protein Science. 19: 658-669. PMID 20082308 DOI: 10.1002/Pro.334  0.445
2010 Philipp S, Puchert M, Adam-Klages S, Tchikov V, Winoto-Morbach S, Mathieu S, Deerberg A, Kolker L, Marchesini N, Kabelitz D, Hannun YA, Schütze S, Adam D. The Polycomb group protein EED couples TNF receptor 1 to neutral sphingomyelinase Proceedings of the National Academy of Sciences of the United States of America. 107: 1112-1117. PMID 20080539 DOI: 10.1073/Pnas.0908486107  0.305
2010 Traxlmayr MW, Wesch D, Dohnal AM, Funovics P, Fischer MB, Kabelitz D, Felzmann T. Immune Suppression by γδ T-cells as a Potential Regulatory Mechanism After Cancer Vaccination With IL-12 Secreting Dendritic Cells Journal of Immunotherapy. 33: 40-52. PMID 19952957 DOI: 10.1097/Cji.0B013E3181B51447  0.512
2009 Chiplunkar S, Dhar S, Wesch D, Kabelitz D. gammadelta T cells in cancer immunotherapy: current status and future prospects. Immunotherapy. 1: 663-678. PMID 20635991 DOI: 10.2217/Imt.09.27  0.549
2009 Marischen L, Wesch D, Schröder JM, Wiedow O, Kabelitz D. Human gammadelta T cells produce the protease inhibitor and antimicrobial peptide elafin. Scandinavian Journal of Immunology. 70: 547-52. PMID 19906197 DOI: 10.1111/j.1365-3083.2009.02337.x  0.432
2009 Shojaei H, Oberg HH, Juricke M, Marischen L, Kunz M, Mundhenke C, Gieseler F, Kabelitz D, Wesch D. Toll-like receptors 3 and 7 agonists enhance tumor cell lysis by human gammadelta T cells. Cancer Research. 69: 8710-7. PMID 19887600 DOI: 10.1158/0008-5472.Can-09-1602  0.53
2009 Pietschmann K, Beetz S, Welte S, Martens I, Gruen J, Oberg H-, Wesch D, Kabelitz D. Toll‐Like Receptor Expression and Function in Subsets of Human γδ T Lymphocytes Scandinavian Journal of Immunology. 70: 245-255. PMID 19703014 DOI: 10.1111/J.1365-3083.2009.02290.X  0.511
2009 Paulsen M, Mathew B, Qian J, Lettau M, Kabelitz D, Janssen O. FasL cross-linking inhibits activation of human peripheral T cells. International Immunology. 21: 587-98. PMID 19332441 DOI: 10.1093/Intimm/Dxp028  0.525
2009 Kabelitz D, Schreiber S. [Autoimmunity. Physiological control mechanisms and pathways to autoimmune disease]. Der Internist. 50: 267-75. PMID 19221706 DOI: 10.1007/s00108-008-2249-y  0.374
2009 Lettau M, Paulsen M, Kabelitz D, Janssen O. FasL expression and reverse signalling. Results and Problems in Cell Differentiation. 49: 49-61. PMID 19132323 DOI: 10.1007/400_2008_21  0.406
2009 Linkermann A, Gelhaus C, Lettau M, Qian J, Kabelitz D, Janssen O. Identification of interaction partners for individual SH3 domains of Fas ligand associated members of the PCH protein family in T lymphocytes. Biochimica Et Biophysica Acta. 1794: 168-176. PMID 19041431 DOI: 10.1016/J.Bbapap.2008.10.013  0.394
2009 Ohnesorge S, Oberg H, Peters C, Janssen O, Kabelitz D, Wesch D. Differential Poly(I:C) Responses of Human Vγ9Vδ2 T Cells Stimulated with Pyrophosphates Versus Aminobisphosphonates The Open Immunology Journal. 2: 135-142. DOI: 10.2174/1874226200902010135  0.502
2009 Kabelitz D. Editorial - Introductory Overview: γδ T-Cells at the Cross-Road of Innate and Adaptive Immunity The Open Immunology Journal. 2: 103-105. DOI: 10.2174/1874226200902010103  0.442
2008 Lettau M, Paulsen M, Kabelitz D, Janssen O. Storage, expression and function of Fas ligand, the key death factor of immune cells. Current Medicinal Chemistry. 15: 1684-96. PMID 18673218 DOI: 10.2174/092986708784872384  0.438
2008 Schmidt H, Gelhaus C, Nebendahl M, Lettau M, Watzl C, Kabelitz D, Leippe M, Janssen O. 2-D DIGE analyses of enriched secretory lysosomes reveal heterogeneous profiles of functionally relevant proteins in leukemic and activated human NK cells. Proteomics. 8: 2911-2925. PMID 18655029 DOI: 10.1002/Pmic.200800170  0.439
2008 Alkatout I, Kabelitz D, Kalthoff H, Tiwari S. Prowling wolves in sheep's clothing: the search for tumor stem cells. Biological Chemistry. 389: 799-811. PMID 18627316 DOI: 10.1515/Bc.2008.094  0.358
2008 Paulsen M, Ussat S, Jakob M, Scherer G, Lepenies I, Schütze S, Kabelitz D, Adam-Klages S. Interaction with XIAP prevents full caspase-3/-7 activation in proliferating human T lymphocytes. European Journal of Immunology. 38: 1979-87. PMID 18521960 DOI: 10.1002/Eji.200838211  0.408
2008 Friedrichs B, Siegel S, Kloess M, Barsoum A, Coggin J, Rohrer J, Jakob I, Tiemann M, Heidorn K, Schulte C, Kabelitz D, Steinmann J, Schmitz N, Zeis M. Humoral immune responses against the immature laminin receptor protein show prognostic significance in patients with chronic lymphocytic leukemia. Journal of Immunology (Baltimore, Md. : 1950). 180: 6374-84. PMID 18424761 DOI: 10.4049/Jimmunol.180.9.6374  0.351
2008 Beetz S, Wesch D, Marischen L, Welte S, Oberg H, Kabelitz D. Innate immune functions of human γδ T cells Immunobiology. 213: 173-182. PMID 18406365 DOI: 10.1016/J.Imbio.2007.10.006  0.546
2008 Kabelitz D. Small molecules for the activation of human gammadelta T cell responses against infection. Recent Patents On Anti-Infective Drug Discovery. 3: 1-9. PMID 18221182 DOI: 10.2174/157489108783413218  0.443
2008 Weise JB, Csiszar K, Gottschlich S, Hoffmann M, Schmidt A, Weingartz U, Adamzik I, Heiser A, Kabelitz D, Ambrosch P, Görögh T. Vaccination strategy to target lysyl oxidase-like 4 in dendritic cell based immunotherapy for head and neck cancer. International Journal of Oncology. 32: 317-22. PMID 18202753 DOI: 10.3892/Ijo.32.2.317  0.482
2008 Kabelitz D, Geissler EK, Soria B, Schroeder IS, Fändrich F, Chatenoud L. Toward cell-based therapy of type I diabetes. Trends in Immunology. 29: 68-74. PMID 18182324 DOI: 10.1016/J.It.2007.11.001  0.424
2007 Hinz S, Pagerols-Raluy L, Oberg HH, Ammerpohl O, Grüssel S, Sipos B, Grützmann R, Pilarsky C, Ungefroren H, Saeger HD, Klöppel G, Kabelitz D, Kalthoff H. Foxp3 expression in pancreatic carcinoma cells as a novel mechanism of immune evasion in cancer. Cancer Research. 67: 8344-50. PMID 17804750 DOI: 10.1158/0008-5472.Can-06-3304  0.441
2007 Beetz S, Marischen L, Kabelitz D, Wesch D. Human γδ T cells: Candidates for the development of immunotherapeutic strategies Immunologic Research. 37: 97-111. PMID 17695246 DOI: 10.1007/Bf02685893  0.54
2007 Wrobel P, Shojaei H, Schittek B, Gieseler F, Wollenberg B, Kalthoff H, Kabelitz D, Wesch D. Lysis of a broad range of epithelial tumour cells by human γδ T cells: Involvement of NKG2D ligands and T-cell receptor- versus NKG2D-dependent recognition Scandinavian Journal of Immunology. 66: 320-328. PMID 17635809 DOI: 10.1111/j.1365-3083.2007.01963.x  0.448
2007 Lamprecht P, Gross WL, Kabelitz D. T cell alterations and lymphoid neogenesis favoring autoimmunity in Wegener's granulomatosis Arthritis and Rheumatism. 56: 1725-1727. PMID 17530695 DOI: 10.1002/Art.22693  0.316
2007 Kabelitz D, Wesch D, He W. Perspectives of gammadelta T cells in tumor immunology. Cancer Research. 67: 5-8. PMID 17210676 DOI: 10.1158/0008-5472.Can-06-3069  0.612
2007 Lettau M, Schmidt H, Kabelitz D, Janssen O. Secretory lysosomes and their cargo in T and NK cells Immunology Letters. 108: 10-19. PMID 17097742 DOI: 10.1016/J.Imlet.2006.10.001  0.482
2006 Kabelitz D. Expression and function of Toll-like receptors in T lymphocytes. Current Opinion in Immunology. 19: 39-45. PMID 17129718 DOI: 10.1016/J.COI.2006.11.007  0.352
2006 Kabelitz D, Wesch D, Oberg H. Regulation of regulatory T cells: role of dendritic cells and toll-like receptors. Critical Reviews in Immunology. 26: 291-306. PMID 17073555 DOI: 10.1615/Critrevimmunol.V26.I4.10  0.517
2006 Thon L, Mathieu S, Kabelitz D, Adam D. The murine TRAIL receptor signals caspase-independent cell death through ceramide. Experimental Cell Research. 312: 3808-3821. PMID 17026999 DOI: 10.1016/J.Yexcr.2006.08.017  0.305
2006 Schneider-Brachert W, Tchikov V, Merkel O, Jakob M, Hallas C, Kruse M, Groitl P, Lehn A, Hildt E, Held-Feindt J, Dobner T, Kabelitz D, Krönke M, Schütze S. Inhibition of TNF receptor 1 internalization by adenovirus 14.7K as a novel immune escape mechanism Journal of Clinical Investigation. 116: 2901-2913. PMID 17024246 DOI: 10.1172/Jci23771  0.307
2006 Oberg HH, Wesch D, Lenke J, Kabelitz D. An optimized method for the functional analysis of human regulatory T cells. Scandinavian Journal of Immunology. 64: 353-60. PMID 16918705 DOI: 10.1111/j.1365-3083.2006.01825.x  0.401
2006 Siegel S, Wagner A, Friedrichs B, Wendeler A, Wendel L, Kabelitz D, Steinmann J, Barsoum A, Coggin J, Rohrer J, Dreger P, Schmitz N, Zeis M. Identification of HLA-A*0201-presented T cell epitopes derived from the oncofetal antigen-immature laminin receptor protein in patients with hematological malignancies. Journal of Immunology. 176: 6935-6944. PMID 16709854 DOI: 10.4049/Jimmunol.176.11.6935  0.439
2006 Allam A, Kabelitz D. TCR trans-rearrangements: biological significance in antigen recognition vs the role as lymphoma biomarker. Journal of Immunology. 176: 5707-5712. PMID 16670273 DOI: 10.4049/Jimmunol.176.10.5707  0.382
2006 Lettau M, Qian J, Linkermann A, Latreille M, Larose L, Kabelitz D, Janssen O. The adaptor protein Nck interacts with Fas ligand: Guiding the death factor to the cytotoxic immunological synapse. Proceedings of the National Academy of Sciences of the United States of America. 103: 5911-6. PMID 16595635 DOI: 10.1073/Pnas.0508562103  0.51
2006 Oberg H, Wesch D, Grüssel S, Rose-John S, Kabelitz D. Differential expression of CD126 and CD130 mediates different STAT-3 phosphorylation in CD4+CD25− and CD25high regulatory T cells International Immunology. 18: 555-563. PMID 16540526 DOI: 10.1093/Intimm/Dxh396  0.355
2006 Oberg HH, Lengl-Janssen B, Robertson MJ, Kabelitz D, Janssen O. Differential role of tyrosine phosphorylation in the induction of apoptosis in T cell clones via CD95 or the TCR/CD3-complex. Cell Death and Differentiation. 4: 403-12. PMID 16465259 DOI: 10.1038/sj.cdd.4400256  0.374
2006 Wesch D, Beetz S, Oberg H, Marget M, Krengel K, Kabelitz D. Direct Costimulatory Effect of TLR3 Ligand Poly(I:C) on Human γδ T Lymphocytes Journal of Immunology. 176: 1348-1354. PMID 16424161 DOI: 10.4049/Jimmunol.176.3.1348  0.519
2006 Qian J, Chen W, Lettau M, Podda G, Zörnig M, Kabelitz D, Janssen O. Regulation of FasL expression: a SH3 domain containing protein family involved in the lysosomal association of FasL. Cellular Signalling. 18: 1327-1337. PMID 16318909 DOI: 10.1016/J.Cellsig.2005.10.015  0.367
2005 Adam-Klages S, Adam D, Janssen O, Kabelitz D. Death receptors and caspases: role in lymphocyte proliferation, cell death, and autoimmunity. Immunologic Research. 33: 149-166. PMID 16234581 DOI: 10.1385/Ir:33:2:149  0.351
2005 Rincon-Orozco B, Kunzmann V, Wrobel P, Kabelitz D, Steinle A, Herrmann T. Activation of Vγ9Vδ2 T cells by NKG2D Journal of Immunology. 175: 2144-2151. PMID 16081780 DOI: 10.4049/Jimmunol.175.4.2144  0.567
2005 Holtmeier W, Kabelitz D. gammadelta T cells link innate and adaptive immune responses. Chemical Immunology and Allergy. 86: 151-183. PMID 15976493 DOI: 10.1159/000086659  0.542
2005 Kabelitz D, Marischen L, Oberg H, Holtmeier W, Wesch D. Epithelial Defence by γδ T Cells International Archives of Allergy and Immunology. 137: 73-81. PMID 15832053 DOI: 10.1159/000085107  0.521
2005 Linkermann A, Qian J, Lettau M, Kabelitz D, Janssen O. Considering Fas ligand as a target for therapy Expert Opinion On Therapeutic Targets. 9: 119-134. PMID 15757486 DOI: 10.1517/14728222.9.1.119  0.415
2005 Marget M, Bohlsen D, Davarnia P, Yoo-Ott K, Kabelitz D, Skerra A, Steinmann J. A HLA-Cw6 specific single-chain antibody fragment (scFv) recognizing a natural killer cell receptor epitope. Molecular Immunology. 42: 643-649. PMID 15607823 DOI: 10.1016/J.Molimm.2004.09.013  0.366
2005 Wesch D, Marischen L, Kabelitz D. Regulation of Cytokine Production by γδ T Cells Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents. 4: 153-160. DOI: 10.2174/1568014053507032  0.477
2004 Kabelitz D, Wesch D, Pitters E, Zöller M. Characterization of Tumor Reactivity of Human Vγ9Vδ2 γδ T Cells In Vitro and in SCID Mice In Vivo Journal of Immunology. 173: 6767-6776. PMID 15557170 DOI: 10.4049/Jimmunol.173.11.6767  0.527
2004 Falk M, Ussat S, Reiling N, Wesch D, Kabelitz D, Adam-Klages S. Caspase inhibition blocks human T cell proliferation by suppressing appropriate regulation of IL-2, CD25, and cell cycle-associated proteins. Journal of Immunology (Baltimore, Md. : 1950). 173: 5077-85. PMID 15470051 DOI: 10.4049/Jimmunol.173.8.5077  0.487
2004 Kabelitz D, Wesch D, Pitters E, Zöller M. Potential of human γδ T lymphocytes for immunotherapy of cancer International Journal of Cancer. 112: 727-732. PMID 15386388 DOI: 10.1002/Ijc.20445  0.56
2004 Oberg HH, Sipos B, Kalthoff H, Janssen O, Kabelitz D. Regulation of T-cell death-associated gene 51 (TDAG51) expression in human T-cells Cell Death and Differentiation. 11: 674-684. PMID 15002043 DOI: 10.1038/sj.cdd.4401407  0.453
2004 Kabelitz D. Hard time for anergic cytotoxic T cells Blood. 103: 3-4. DOI: 10.1182/Blood-2003-10-3506  0.523
2004 Lettau M, Qian J, Kabelitz D, Janssen O. Activation‐dependent FasL expression in T lymphocytes and Natural Killer cells Signal Transduction. 4: 206-211. DOI: 10.1002/Sita.200400037  0.466
2003 Kabelitz D, Wesch D. Features and functions of gamma delta T lymphocytes: focus on chemokines and their receptors. Critical Reviews in Immunology. 23: 339-370. PMID 15030305 DOI: 10.1615/Critrevimmunol.V23.I56.10  0.507
2003 Janssen O, Qian J, Linkermann A, Kabelitz D. CD95 ligand--death factor and costimulatory molecule? Cell Death & Differentiation. 10: 1215-1225. PMID 12894217 DOI: 10.1038/Sj.Cdd.4401305  0.429
2003 Wesch D, Kabelitz D. Differential expression of natural killer receptors on Vdelta1 gammadelta T cells in HIV-1-infected individuals. Journal of Acquired Immune Deficiency Syndromes. 33: 420-425. PMID 12869830 DOI: 10.1097/00126334-200308010-00002  0.474
2003 Siegel S, Wagner A, Kabelitz D, Marget M, Coggin J, Barsoum A, Rohrer J, Schmitz N, Zeis M. Induction of cytotoxic T-cell responses against the oncofetal antigen-immature laminin receptor for the treatment of hematologic malignancies Blood. 102: 4416-4423. PMID 12869512 DOI: 10.1182/Blood-2003-01-0198  0.506
2003 Zeis M, Siegel S, Wagner A, Schmitz M, Marget M, Kühl-Burmeister R, Adamzik I, Kabelitz D, Dreger P, Schmitz N, Heiser A. Generation of Cytotoxic Responses in Mice and Human Individuals Against Hematological Malignancies Using Survivin-RNA-Transfected Dendritic Cells Journal of Immunology. 170: 5391-5397. PMID 12759413 DOI: 10.4049/Jimmunol.170.11.5391  0.449
2003 Linkermann A, Qian J, Kabelitz D, Janssen O. The Fas ligand as a cell death factor and signal transducer Signal Transduction. 3: 33-46. DOI: 10.1002/Sita.200300022  0.494
2002 Glatzel A, Entschladen F, Zollner TM, Kraiczy P, Brade V, Kaufmann R, Janssen O, Lengl-Janßen B, Wesch D, Kabelitz D. The responsiveness of human Vδ1 γδ T cells to Borrelia burgdorferi is largely restricted to synovial-fluid cells from patients with Lyme arthritis The Journal of Infectious Diseases. 186: 1043-1046. PMID 12232849 DOI: 10.1086/342949  0.499
2002 Dobmeyer TS, Dobmeyer R, Wesch D, Helm EB, Hoelzer D, Kabelitz D. Reciprocal alterations of Th1/Th2 function in gammadelta T-cell subsets of human immunodeficiency virus-1-infected patients. British Journal of Haematology. 118: 282-8. PMID 12100163 DOI: 10.1046/j.1365-2141.2002.03555.x  0.408
2002 Ussat S, Werner U, Kruse M, Lüschen S, Scherer G, Kabelitz D, Adam-Klages S. Upregulation of p21WAF1/Cip1 precedes tumor necrosis factor-induced necrosis-like cell death ☆ Biochemical and Biophysical Research Communications. 294: 672-679. PMID 12056822 DOI: 10.1016/S0006-291X(02)00532-6  0.387
2002 Ghadimi MP, Sanzenbacher R, Thiede B, Wenzel J, Jing Q, Plomann M, Borkhardt A, Kabelitz D, Janssen O. Identification of interaction partners of the cytosolic polyproline region of CD95 ligand (CD178). Febs Letters. 519: 50-8. PMID 12023017 DOI: 10.1016/S0014-5793(02)02709-6  0.428
2002 Glatzel A, Wesch D, Schiemann F, Brandt E, Janssen O, Kabelitz D. Patterns of Chemokine Receptor Expression on Peripheral Blood γδ T Lymphocytes: Strong Expression of CCR5 Is a Selective Feature of Vδ2/Vγ9 γδ T Cells Journal of Immunology. 168: 4920-4929. PMID 11994442 DOI: 10.4049/Jimmunol.168.10.4920  0.536
2002 Adam D, Heinrich M, Kabelitz D, Schütze S. Ceramide: does it matter for T cells? Trends in Immunology. 23: 1-4. PMID 11801441 DOI: 10.1016/S1471-4906(01)02091-9  0.501
2001 Wesch D, Glatzel A, Kabelitz D. Differentiation of Resting Human Peripheral Blood γδ T Cells toward Th1- or Th2-Phenotype Cellular Immunology. 212: 110-117. PMID 11748927 DOI: 10.1006/Cimm.2001.1850  0.445
2001 Wenzel J, Sanzenbacher R, Ghadimi M, Lewitzky M, Zhou Q, Kaplan DR, Kabelitz D, Feller SM, Janssen O. Multiple interactions of the cytosolic polyproline region of the CD95 ligand: hints for the reverse signal transduction capacity of a death factor. Febs Letters. 509: 255-62. PMID 11741599 DOI: 10.1016/S0014-5793(01)03174-X  0.484
2001 Weidmann E, Boehrer S, Chow KU, Engels K, Harder L, Hinz T, Janssen O, Kriener S, Rummel MJ, Siebert R, Kabelitz D, Hansmann ML, Hoelzer D, Mitrou PS. Treatment of aggressive, or progressing indolent peripheral T- and NK-cell neoplasias by combination of fludarabine, cyclophosphamide and doxorubicine. Onkologie. 24: 162-4. PMID 11441297 DOI: 10.1159/000050305  0.379
2001 Hinz T, Weidmann E, Kabelitz D. Dual TCR-expressing T lymphocytes in health and disease. International Archives of Allergy and Immunology. 125: 16-20. PMID 11385284 DOI: 10.1159/000053792  0.505
2001 Hinz T, Flindt S, Marx A, Janssen O, Kabelitz D. Inhibition of protein synthesis by the T cell receptor-inducible human TDAG51 gene product Cellular Signalling. 13: 345-352. PMID 11369516 DOI: 10.1016/S0898-6568(01)00141-3  0.49
2001 Stepczynska A, Lauber K, Engels IH, Janssen O, Kabelitz D, Wesselborg S, Schulze-Osthoff K. Staurosporine and conventional anticancer drugs induce overlapping, yet distinct pathways of apoptosis and caspase activation. Oncogene. 20: 1193-1202. PMID 11313863 DOI: 10.1038/Sj.Onc.1204221  0.31
2001 Tchikov V, Winoto-Morbach S, Kabelitz D, Krönke M, Schütze S. Adhesion of immunomagnetic particles targeted to antigens and cytokine receptors on tumor cells determined by magnetophoresis Journal of Magnetism and Magnetic Materials. 225: 285-293. DOI: 10.1016/S0304-8853(00)01252-X  0.339
2000 Janssen O, Sanzenbacher R, Kabelitz D. Regulation of activation-induced cell death of mature T-lymphocyte populations. Cell and Tissue Research. 301: 85-99. PMID 10928283 DOI: 10.1007/S004419900155  0.537
2000 Kabelitz D, Glatzel A, Wesch D. Antigen Recognition by Human γδ T Lymphocytes International Archives of Allergy and Immunology. 122: 1-7. PMID 10859464 DOI: 10.1159/000024353  0.504
2000 Hinz T, Allam A, Wesch D, Schindler D, Kabelitz D. Cell-surface expression of transrearranged Vgamma-cbeta T-cell receptor chains in healthy donors and in ataxia telangiectasia patients. British Journal of Haematology. 109: 201-10. PMID 10848801 DOI: 10.1046/j.1365-2141.2000.01962.x  0.388
2000 Lüschen S, Ussat S, Scherer G, Kabelitz D, Adam-Klages S. Sensitization to death receptor cytotoxicity by inhibition of fas-associated death domain protein (FADD)/caspase signaling. Requirement of cell cycle progression. Journal of Biological Chemistry. 275: 24670-24678. PMID 10827087 DOI: 10.1074/Jbc.M003280200  0.391
2000 Kabelitz D. Effector functions and control of human gammadelta T-cell activation. Microbes and Infection. 1: 255-61. PMID 10801238 DOI: 10.1016/S1286-4579(99)80042-2  0.37
2000 Janssen O, Stocker A, Sanzenbacher R, Oberg HH, Siddiqi MA, Kabelitz D. Differential regulation of activation-induced cell death in individual human T cell clones. International Archives of Allergy and Immunology. 121: 183-93. PMID 10729776 DOI: 10.1159/000024316  0.501
1999 Kabelitz D, Wesch D, Hinz T. γδ T cells, their T cell receptor usage and role in human diseases Springer Seminars in Immunopathology. 21: 55-75. DOI: 10.1007/s002810050052  0.421
1999 Kabelitz D, Wesch D, Hinz T. ?? T cells, their T cell receptor usage and role in human diseases Springer Seminars in Immunopathology. 21: 55-76. DOI: 10.1007/BF00815178  0.421
1998 Wesch D, Hinz T, Kabelitz D. Analysis of the TCR Vgamma repertoire in healthy donors and HIV-1-infected individuals. International Immunology. 10: 1067-1075. PMID 9723692 DOI: 10.1093/Intimm/10.8.1067  0.315
1998 Dobmeyer TS, Dobmeyer JM, Klein SA, Wesch D, Wagner S, Helm EB, Hoelzer D, Rossol R, Kabelitz D. Mechanism of gamma sigma T-cell-mediated inhibition of stem cell differentiation in vitro: possible relevance for myelosuppression in HIV-infected individuals. Cellular Immunology. 184: 26-36. PMID 9626332 DOI: 10.1006/Cimm.1998.1257  0.455
1998 Schulz H, Karau A, Filsinger S, Schoels M, Kabelitz D, Richter R, Hänsch GM. Tubular epithelial cells as accessory cells for superantigen-induced T cell activation. Experimental Nephrology. 6: 67-73. PMID 9523175 DOI: 10.1159/000020506  0.448
1998 Kabelitz D, Janssen O. Antigen-Induced Death of T-Lymphocytes Pediatric Pathology & Molecular Medicine. 18: 329-354. DOI: 10.1080/15513819809168794  0.327
1998 Kaufmann S, Kabelitz D. Introduction: The immune response to infectious agents Methods in Microbiology. 25: 1-19. DOI: 10.1016/S0580-9517(08)70675-5  0.38
1997 Oberg HH, Lengl-Janssen B, Kabelitz D, Janssen O. Activation-induced T cell death: resistance or susceptibility correlate with cell surface fas ligand expression and T helper phenotype. Cellular Immunology. 181: 93-100. PMID 9344501 DOI: 10.1006/CIMM.1997.1200  0.409
1997 Hinz T, Wesch D, Halary F, Marx S, Choudhary A, Arden B, Janssen O, Bonneville M, Kabelitz D. Identification of the complete expressed human TCR V(γ) repertoire by flow cytometry International Immunology. 9: 1065-1072. PMID 9263003 DOI: 10.1093/Intimm/9.8.1065  0.425
1997 Fischer S, Scheffler A, Kabelitz D. Oligoclonal in vitro response of CD4 T cells to vesicles of mistletoe extracts in mistletoe-treated cancer patients. Cancer Immunology, Immunotherapy : Cii. 44: 150-6. PMID 9191874 DOI: 10.1007/s002620050367  0.378
1997 Fischer S, Scheffler A, Kabelitz D. Stimulation of the specific immune system by mistletoe extracts. Anti-Cancer Drugs. S33-7. PMID 9179365 DOI: 10.1097/00001813-199704001-00008  0.412
1997 Kabelitz D, Janssen O. Antigen-induced death of T-lymphocytes. Frontiers in Bioscience : a Journal and Virtual Library. 2: d61-77. PMID 9159213 DOI: 10.2741/A175  0.447
1997 Wesch D, Marx S, Kabelitz D. Comparative analysis of αβ and γδ T cell activation by Mycobacterium tuberculosis and isopentenyl pyrophosphate European Journal of Immunology. 27: 952-956. PMID 9130649 DOI: 10.1002/eji.1830270422  0.422
1997 Kabelitz D, Hinz T, Dobmeyer T, Mentzel U, Marx S, Böhme A, Arden B, Rossol R, Hoelzer D. Clonal expansion of Vgamma3/Vdelta3-expressing gammadelta T cells in an HIV-1/2-negative patient with CD4 T-cell deficiency. British Journal of Haematology. 96: 266-71. PMID 9029011 DOI: 10.1046/j.1365-2141.1997.d01-2027.x  0.4
1997 Fischer S, Scheffler A, Kabelitz D. Activation of human gamma delta T-cells by heat-treated mistletoe plant extracts. Immunology Letters. 52: 69-72. PMID 8905398 DOI: 10.1016/0165-2478(96)02584-9  0.372
1997 Kabelitz D, Pohl T, Oberg HH, Pechhold K, Dobmeyer T, Rossol R. Apoptosis of mature T lymphocytes: putative role in the regulation of cellular immune responses and in the pathogenesis of HIV infection. Progress in Molecular and Subcellular Biology. 16: 58-71. PMID 8822792 DOI: 10.1007/978-3-642-79850-4_4  0.415
1997 Arden B, Wilbert O, Weber-Arden J, Kabelitz D. Intrathymic T-cell receptor δ-chain repertoire selection during ontogeny Immunology Letters. 56: 88. DOI: 10.1016/S0165-2478(97)85343-6  0.333
1996 Janssen O, Lengl-Janssen B, Oberg HH, Robertson MJ, Kabelitz D. Induction of cell death via Fas (CD95, Apo-1) may be associated with but is not dependent on Fas-induced tyrosine phosphorylation. Immunology Letters. 49: 63-9. PMID 8964611 DOI: 10.1016/0165-2478(95)02482-4  0.308
1996 Hinz T, Marx S, Nerl C, Kabelitz D. Clonal expansion of γδ T cells expressing two distinct T-cell receptors British Journal of Haematology. 94: 62-64. PMID 8757509 DOI: 10.1046/j.1365-2141.1996.d01-1779.x  0.42
1996 Wesch D, Kabelitz D, Friese K, Pechhold K. Mycobacteria-reactive gamma delta T cells in HIV-infected individuals: lack of V gamma 9 cell responsiveness is due to deficiency of antigen-specific CD4 T helper type 1 cells. European Journal of Immunology. 26: 557-62. PMID 8605921 DOI: 10.1002/EJI.1830260309  0.359
1996 Pohl T, Pechhold K, Oberg HH, Wilbert OM, Kabelitz D. Antigen-induced death of alloreactive human T-lymphocytes occurs in the absence of low molecular weight DNA fragmentation. Cellular Immunology. 166: 187-95. PMID 7497520 DOI: 10.1006/CIMM.1995.9979  0.412
1995 Kabelitz D, Pohl T, Pechhold K. T cell apoptosis triggered via the CD3/T cell receptor complex and alternative activation pathways. Current Topics in Microbiology and Immunology. 200: 1-14. PMID 7543402 DOI: 10.1007/978-3-642-79437-7_1  0.427
1994 Davodeau F, Peyrat MA, Gaschet J, Hallet MM, Triebel F, Vié H, Kabelitz D, Bonneville M. Surface expression of functional T cell receptor chains formed by interlocus recombination on human T lymphocytes Journal of Experimental Medicine. 180: 1685-1691. PMID 7964454 DOI: 10.1084/jem.180.5.1685  0.315
1994 Pechhold K, Pohl T, Kabelitz D. Rapid quantification of lymphocyte subsets in heterogeneous cell populations by flow cytometry. Cytometry. 16: 152-9. PMID 7924684 DOI: 10.1002/CYTO.990160209  0.371
1994 He W, Kabelitz D. Cytokines Involved in Intrathymic T Cell Development International Archives of Allergy and Immunology. 105: 203-210. PMID 7920022 DOI: 10.1159/000236759  0.482
1993 Pechhold K, Kabelitz D. Human peripheral blood gamma delta T cells are uniformly sensitive to destruction by the lysosomotropic agents leucine methyl ester and leucyl leucine methyl ester. European Journal of Immunology. 23: 562-5. PMID 8436187 DOI: 10.1002/EJI.1830230240  0.423
1993 Metzger R, Melmer G, Schondelmaier S, Heckl-Ostreicher B, Nerl C, Pechhold K, Epplen JT, Kabelitz D. Leukaemic T cells from patients with chronic lymphocytic leukaemia of T-cell origin respond to Staphylococcus aureus enterotoxin superantigens. Scandinavian Journal of Immunology. 37: 245-50. PMID 8434235 DOI: 10.1111/j.1365-3083.1993.tb01762.x  0.438
1993 Khirwadkar K, Zilow G, Oppermann M, Kabelitz D, Rother K. Interleukin-4 augments production of the third complement component by the alveolar epithelial cell line A549. International Archives of Allergy and Immunology. 100: 35-41. PMID 8428161 DOI: 10.1159/000236384  0.365
1993 Kabelitz D. Human gamma delta T lymphocytes. International Archives of Allergy and Immunology. 102: 1-9. PMID 8400880 DOI: 10.1159/000236544  0.303
1993 Kabelitz D, Pohl T, Pechhold K. Activation-induced cell death (apoptosis) of mature peripheral T lymphocytes. Immunology Today. 14: 338-9. PMID 8363721 DOI: 10.1016/0167-5699(93)90231-9  0.45
1993 Wesselborg S, Kabelitz D. Activation-driven death of human T cell clones: time course kinetics of the induction of cell shrinkage, DNA fragmentation, and cell death. Cellular Immunology. 148: 234-41. PMID 8098667 DOI: 10.1006/CIMM.1993.1106  0.416
1993 He W, Kabelitz D. Differential effects of interleukin-7 and interleukin-2 on T-cell receptor gamma delta-expressing cells within CD4-CD8- postnatal human thymocytes. International Archives of Allergy and Immunology. 102: 321-6. PMID 7902153 DOI: 10.1159/000236578  0.432
1993 Wesselborg S, Prüfer U, Wild M, Schraven B, Meuer SC, Kabelitz D. Triggering via the alternative CD2 pathway induces apoptosis in activated human T lymphocytes. European Journal of Immunology. 23: 2707-10. PMID 7691614 DOI: 10.1002/eji.1830231050  0.384
1993 Bender A, Heckl-Östreicher B, Grondal EJM, Kabelitz D. Clonal Specificity of Human γδ T Cells: Vγ9+ T-Cell Clones Frequently Recognize Plasmodiumfalciparum Merozoites, Mycobacterium tuberculosis, and Group-A Streptococci International Archives of Allergy and Immunology. 100: 12-18. PMID 7679021 DOI: 10.1159/000236381  0.485
1992 Duan XC, Kabelitz D. Stimulation of CD2-negative T cells by staphylococcal enterotoxin superantigens. Immunology Letters. 29: 219-22. PMID 1685147 DOI: 10.1016/0165-2478(91)90173-8  0.347
1992 Khirwadkar K, Schmitz M, Kabelitz D. Frequency Analysis of Allergen-Reactive T-Lymphocytes in Individuals Allergic against the House-Dust Mite Dermatophagoides pteronyssinus International Archives of Allergy and Immunology. 98: 6-12. PMID 1624207 DOI: 10.1159/000236158  0.505
1992 Dietl J, Ruck P, Horny HP, Handgretinger R, Marzusch K, Ruck M, Kaiserling E, Griesser H, Kabelitz D. The decidua of early human pregnancy: Immunohistochemistry and function of immunocompetent cells Gynecologic and Obstetric Investigation. 33: 197-204. PMID 1505806 DOI: 10.1159/000294882  0.315
1992 Metzger R, Heckl-Ostreicher B, Nerl C, Schondelmaier S, Kabelitz D. Immunological studies of gamma delta T cells in a case of large granular lymphocyte (LGL) leukemia: leukemic gamma delta+ T cells are resistant to growth stimulation in vitro but respond to interferon-alpha treatment in vivo. Leukemia Research. 16: 1087-95. PMID 1434745 DOI: 10.1016/0145-2126(92)90047-B  0.356
1992 Bender A, Kabelitz D. Preferential activation of peripheral blood V gamma 9+ gamma/delta T cells by group A, B and C but not group D or F streptococci. Clinical and Experimental Immunology. 89: 301-4. PMID 1386299 DOI: 10.1111/j.1365-2249.1992.tb06949.x  0.336
1992 Kabelitz D, Wesselborg S. Life and death of a superantigen-reactive human CD4+ T cell clone: staphylococcal enterotoxins induce death by apoptosis but simultaneously trigger a proliferative response in the presence of HLA-DR+ antigen-presenting cells. International Immunology. 4: 1381-1388. PMID 1363055 DOI: 10.1093/Intimm/4.12.1381  0.458
1991 Dietl J, Horny HP, Ruck P, Marzusch K, Kaiserling E, Griesser H, Kabelitz D. Intradecidual T lymphocytes lack immunohistochemically detectable T-cell receptors. American Journal of Reproductive Immunology (New York, N.Y. : 1989). 24: 33-6. PMID 2288645 DOI: 10.1111/j.1600-0897.1990.tb01034.x  0.352
1991 Kaufmann SHE, Kabelitz D. Gamma/delta T lymphocytes and heat shock proteins. Current Topics in Microbiology and Immunology. 167: 191-207. PMID 2055096 DOI: 10.1007/978-3-642-75875-1_11  0.352
1991 Dietl J, Horny HP, Ruck P, Marzusch K, Kaiserling E, Griesser H, Kabelitz D. Intradecidual T lymphocytes lack T-cell receptors. American Journal of Obstetrics and Gynecology. 164: 702. PMID 2036104 DOI: 10.1016/S0002-9378(11)80055-4  0.401
1991 Kabelitz D, Wesselborg S, Pechold K, Janssen O. Activation and deactivation of cloned gamma/delta T cells. Current Topics in Microbiology and Immunology. 173: 197-202. PMID 1833143 DOI: 10.1007/978-3-642-76492-9_27  0.388
1991 Kabelitz D, Bender A, Prospero T, Wesselborg S, Janssen O, Pechhold K. The primary response of human gamma/delta + T cells to Mycobacterium tuberculosis is restricted to V gamma 9-bearing cells. The Journal of Experimental Medicine. 173: 1331-8. PMID 1827825 DOI: 10.1084/JEM.173.6.1331  0.332
1991 Wesselborg S, Janssen O, Pechhold K, Kabelitz D. Selective activation of gamma/delta + T cell clones by single anti-CD2 antibodies. The Journal of Experimental Medicine. 173: 297-304. PMID 1703204 DOI: 10.1084/JEM.173.2.297  0.347
1991 Kabelitz D, Pechhold K, Bender A, Wesselborg S, Wesch D, Friese K, Janssen O. Activation and activation-driven death of human gamma/delta T cells. Immunological Reviews. 120: 71-88. PMID 1677929 DOI: 10.1111/j.1600-065X.1991.tb00588.x  0.43
1990 Jooss J, Eiermann TH, Wagner H, Kabelitz D. Interleukin 2 production by alloantigen-stimulated CD4+ and CD8+ human T cell subsets: frequency of HLA class I or class II-reactive precursor cells and clonal specificity of activated T cells. Immunobiology. 179: 366-81. PMID 2575597 DOI: 10.1016/S0171-2985(89)80042-7  0.301
1990 Bender A, Kabelitz D. CD4-CD8- human T cells: phenotypic heterogeneity and activation requirements of freshly isolated "double-negative" T cells. Cellular Immunology. 128: 542-54. PMID 2141552 DOI: 10.1016/0008-8749(90)90047-U  0.343
1990 Kabelitz D, da Silva Lobo ML, Schürmann G, Hofmann WJ, Otto G. Presence of gamma/delta T-cell receptor-expressing T cells in liver biopsies following liver transplantation. Human Immunology. 28: 167-9. PMID 2141010 DOI: 10.1016/0198-8859(90)90014-G  0.317
1990 Kabelitz D, Bender A, Schondelmaier S, Schoel B, Kaufmann SH. A large fraction of human peripheral blood gamma/delta + T cells is activated by Mycobacterium tuberculosis but not by its 65-kD heat shock protein. The Journal of Experimental Medicine. 171: 667-79. PMID 2137854 DOI: 10.1084/JEM.171.3.667  0.417
1989 Kabelitz D, Al-Gorany KH. Esculetin inhibits T cell activation without suppressing IL-2 production or IL-2 receptor expression. Immunology Letters. 20: 241-5. PMID 2654016 DOI: 10.1016/0165-2478(89)90087-4  0.304
1989 Kabelitz D, Conradt P, Schondelmaier S, Wagner H, Haars R. A novel subset of CD2-, CD3/T cell receptor alpha/beta+ human peripheral blood T cells. Phenotypic and functional characterization of interleukin 2-dependent CD2-CD3+ T cell clones. The Journal of Experimental Medicine. 170: 559-69. PMID 2569027 DOI: 10.1084/JEM.170.2.559  0.308
1989 Kabelitz D, Brucker C, Wagner H, Fleischer B. A previously unrecognized large fraction of cytotoxic lymphocyte precursors is present in CD4+ human peripheral blood T cells. Cellular Immunology. 118: 285-97. PMID 2562929 DOI: 10.1016/0008-8749(89)90378-X  0.356
1989 Kabelitz D. Human cytotoxic lymphocytes. IV. Frequency and clonal specificity of CD8+CD16-(Leu2+Leu11-) and CD16+CD3-(Leu11+Leu4-) cytotoxic lymphocyte precursors activated by alloantigen or K562 stimulator cells. Cellular Immunology. 121: 298-305. PMID 2525425 DOI: 10.1016/0008-8749(89)90028-2  0.34
1989 Janssen O, Nerl C, Kabelitz D. T cells in B-cell chronic lymphocytic leukemia: quantitative assessment of cytotoxic and interleukin-2-producing lymphocyte precursors by limiting dilution analysis Blood. 73: 1622-1626. DOI: 10.1182/blood.v73.6.1622.bloodjournal7361622  0.401
1989 Janssen O, Nerl C, Kabelitz D. T cells in B-cell chronic lymphocytic leukemia: quantitative assessment of cytotoxic and interleukin-2-producing lymphocyte precursors by limiting dilution analysis Blood. 73: 1622-1626. DOI: 10.1182/BLOOD.V73.6.1622.1622  0.401
1988 Heeg K, Steeg C, Kabelitz D, Reimann J, Wagner H. Clonal specificity analysis of mitogen-activated murine T lymphoblasts. Immunobiology. 175: 431-46. PMID 3501396 DOI: 10.1016/S0171-2985(87)80071-2  0.349
1988 Jooss J, Zanker B, Wagner H, Kabelitz D. Quantitative assessment of interleukin-2-producing alloreactive human T cells by limiting dilution analysis. Journal of Immunological Methods. 112: 85-90. PMID 2969933 DOI: 10.1016/0022-1759(88)90037-3  0.322
1988 Kabelitz D, Janssen O, Brucker C. Use of OKT3 hybridoma cells to clonally activate CD3+ human T lymphocytes. Journal of Immunological Methods. 107: 211-6. PMID 2964489 DOI: 10.1016/0022-1759(88)90220-7  0.347
1987 Brucker C, Reimann J, Wagner H, Kabelitz D. Clonal activation of cytotoxic lymphocyte precursors by monoclonal anti-CD3 antibody: analysis of feeder cell requirements. Immunology Letters. 14: 121-5. PMID 3108144 DOI: 10.1016/0165-2478(87)90090-3  0.422
1986 Kabelitz D, Heeg K, Wagner H, Reimann J. T-cell reactivity to polymorphic MHC determinants. III. Alloreactive and allorestricted T cells. Current Topics in Microbiology and Immunology. 126: 275-89. PMID 3487427 DOI: 10.1007/978-3-642-71152-7_32  0.414
1986 Reimann J, Heeg K, Kabelitz D, Wagner H, Miller RG. T-cell reactivity to polymorphic MHC determinants. I. MHC-guided T-cell reactivity. Current Topics in Microbiology and Immunology. 126: 243-57. PMID 3487426 DOI: 10.1007/978-3-642-71152-7_30  0.413
1986 Heeg K, Kabelitz D, Wagner H, Reimann J. T-cell reactivity to polymorphic MHC determinants. II. Self-reactive and self-restricted T cells. Current Topics in Microbiology and Immunology. 126: 259-74. PMID 2941243 DOI: 10.1007/978-3-642-71152-7_31  0.316
1985 Heeg K, Reimann J, Kabelitz D, Hardt C, Wagner H. A rapid colorimetric assay for the determination of IL-2-producing helper T cell frequencies. Journal of Immunological Methods. 77: 237-46. PMID 3156935 DOI: 10.1016/0022-1759(85)90036-5  0.306
1985 Kabelitz D, Herzog WR, Zanker B, Wagner H. Human cytotoxic T lymphocytes. I. Limiting-dilution analysis of alloreactive cytotoxic T-lymphocyte precursor frequencies. Scandinavian Journal of Immunology. 22: 329-35. PMID 2413529 DOI: 10.1111/j.1365-3083.1985.tb01888.x  0.387
1985 Kabelitz D. Modulation of natural killing by tumor promoters: the regulatory influence of adherent cells varies with the type of target cell. Immunobiology. 169: 436-46. PMID 2408998 DOI: 10.1016/S0171-2985(85)80023-1  0.308
1983 Kabelitz D, Klareskog L, Simonsson B. Density separation of chronic lymphocytic leukemia cells: low-density non-T cells are efficient stimulator cells in allogeneic and autologous mixed leukocyte reaction. Clinical Immunology and Immunopathology. 26: 287-95. PMID 6307566 DOI: 10.1016/0090-1229(83)90147-2  0.372
1983 Canonica GW, Kabelitz D, Sjöberg O, Aigrain Y, Wigzell H. Density distribution profiles of T cells: TM, TG and TA cells and response patterns in autologous versus allogeneic MLRs. Scandinavian Journal of Immunology. 16: 243-8. PMID 6216580 DOI: 10.1111/j.1365-3083.1982.tb00719.x  0.39
1983 Kabelitz D, Canonica GW, Sjöberg O, Klareskog L, Wigzell H. Inhibition of autologous mixed lymphocyte reaction by aggregated IgG molecules. European Journal of Immunology. 12: 687-91. PMID 6216111 DOI: 10.1002/EJI.1830120812  0.446
1982 Klareskog L, Forsum U, Scheynius A, Kabelitz D, Wigzell H. Evidence in support of a self-perpetuating HLA-DR-dependent delayed-type cell reaction in rheumatoid arthritis. Proceedings of the National Academy of Sciences of the United States of America. 79: 3632-6. PMID 6980416 DOI: 10.1073/PNAS.79.11.3632  0.389
1982 Kabelitz D, Tötterman TH, Gidlund M, Nilsson K, Wigzell H. Activation of human T lymphocytes by 12-O-tetradecanoylphorbol-13-acetate: role of accessory cells and interaction with lectins and allogeneic cells. Cellular Immunology. 70: 277-86. PMID 6215126 DOI: 10.1016/0008-8749(82)90329-X  0.373
1982 Kabelitz D, Fink U, Reichert A, Rastetter J. Alloantigen-induced suppressor- and memory cells in chronic lymphocytic leukemia Immunobiology. 161: 457-463. PMID 6212533 DOI: 10.1016/S0171-2985(82)80048-X  0.399
1982 Klareskog L, Forsum U, Kabelitz D, Plöen L, Sundström C, Nilsson K, Wigren A, Wigzell H. Immune functions of human synovial cells. Phenotypic and T cell regulatory properties of macrophage-like cells that express HLA-DR. Arthritis and Rheumatism. 25: 488-501. PMID 6211176 DOI: 10.1002/ART.1780250502  0.409
1981 Kabelitz D, Fink U, Aigrain Y, Reichert A. Enrichment of MLR-activated human suppressor cells by discontinuous density-gradient centrifugation Immunobiology. 158: 403-415. PMID 6455379 DOI: 10.1016/S0171-2985(81)80011-3  0.356
1981 Kabelitz D, Fink U, Reichert A. Isolation of T lymphocytes in chronic lymphocytic leukaemia by depletion of mouse rosette-forming cells Scandinavian Journal of Immunology. 13: 219-224. PMID 6453422 DOI: 10.1111/j.1365-3083.1981.tb00128.x  0.353
Show low-probability matches.